DC Circ. Tosses Watson's Appeal Of Vascepa FDA Remand
The D.C. Circuit on Wednesday shot down Watson Laboratories Inc.'s premature attempt to appeal a district court order vacating the U.S. Food and Drug Administration's decision to limit market exclusivity for...To view the full article, register now.
Already a subscriber? Click here to view full article